Bioextrax AB (publ) (BIOEX.ST)

SEK 3.4

(0.59%)

EBITDA Summary of Bioextrax AB (publ)

  • Bioextrax AB (publ)'s latest annual EBITDA in 2023 was -20.64 Million SEK , down -7.49% from previous year.
  • Bioextrax AB (publ)'s latest quarterly EBITDA in 2024 Q2 was -4.52 Million SEK , up 0.9% from previous quarter.
  • Bioextrax AB (publ) reported an annual EBITDA of -18.19 Million SEK in 2022, down -84.18% from previous year.
  • Bioextrax AB (publ) reported an annual EBITDA of -10.17 Million SEK in 2021, down -96.21% from previous year.
  • Bioextrax AB (publ) reported a quarterly EBITDA of -4.94 Million SEK for 2024 Q1, up 23.03% from previous quarter.
  • Bioextrax AB (publ) reported a quarterly EBITDA of -4.77 Million SEK for 2023 Q1, up 27.53% from previous quarter.

Annual EBITDA Chart of Bioextrax AB (publ) (2023 - 2018)

Historical Annual EBITDA of Bioextrax AB (publ) (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -20.64 Million SEK -7.49%
2022 -18.19 Million SEK -84.18%
2021 -10.17 Million SEK -96.21%
2020 -5.39 Million SEK -71.1%
2019 -1.87 Million SEK -111.22%
2018 -854.56 Thousand SEK 0.0%

Peer EBITDA Comparison of Bioextrax AB (publ)

Name EBITDA EBITDA Difference
Axolot Solutions Holding AB (publ) -13.64 Million SEK -51.275%
CirChem AB (publ) -15.51 Million SEK -33.07%
Norditek Group AB (publ) 10.12 Million SEK 303.831%
Scandinavian Enviro Systems AB (publ) -79.48 Million SEK 74.025%
Studsvik AB (publ) 101.02 Million SEK 120.436%